Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma.
Saved in:
| Title: | Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma. |
|---|---|
| Authors: | Sakemura R; T Cell Engineering.; Division of Hematology., Hefazi M; T Cell Engineering.; Division of Hematology., Siegler EL; T Cell Engineering.; Division of Hematology., Cox MJ; T Cell Engineering.; Division of Hematology., Larson DP; Division of Hematopathology., Hansen MJ; Department of Immunology., Manriquez Roman C; T Cell Engineering.; Division of Hematology.; Mayo Clinic Graduate School of Biomedical Sciences.; Department of Molecular Medicine., Schick KJ; T Cell Engineering.; Division of Hematology.; Mayo Clinic Graduate School of Biomedical Sciences.; Department of Molecular Pharmacology and Experimental Therapeutics, and., Can I; T Cell Engineering.; Division of Hematology.; Mayo Clinic Graduate School of Biomedical Sciences., Tapper EE; T Cell Engineering.; Division of Hematology., Horvei P; T Cell Engineering., Adada MM; T Cell Engineering.; Division of Hematology., Bezerra ED; T Cell Engineering.; Division of Hematology., Kankeu Fonkoua LA; T Cell Engineering.; Division of Hematology., Ruff MW; T Cell Engineering.; Department of Neurology, Mayo Clinic, Rochester, MN; and., Nevala WK; Department of Immunology., Walters DK; Department of Immunology., Parikh SA; Division of Hematology., Lin Y; Division of Hematology., Jelinek DF; Department of Immunology., Kay NE; Division of Hematology., Bergsagel PL; Department of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ., Kenderian SS; T Cell Engineering.; Division of Hematology.; Department of Immunology.; Department of Molecular Medicine. |
| Source: | Blood [Blood] 2022 Jun 30; Vol. 139 (26), pp. 3708-3721. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35090171 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sakemura+R%22">Sakemura R</searchLink>; T Cell Engineering.; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Hefazi+M%22">Hefazi M</searchLink>; T Cell Engineering.; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Siegler+EL%22">Siegler EL</searchLink>; T Cell Engineering.; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Cox+MJ%22">Cox MJ</searchLink>; T Cell Engineering.; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Larson+DP%22">Larson DP</searchLink>; Division of Hematopathology.<br /><searchLink fieldCode="AU" term="%22Hansen+MJ%22">Hansen MJ</searchLink>; Department of Immunology.<br /><searchLink fieldCode="AU" term="%22Manriquez+Roman+C%22">Manriquez Roman C</searchLink>; T Cell Engineering.; Division of Hematology.; Mayo Clinic Graduate School of Biomedical Sciences.; Department of Molecular Medicine.<br /><searchLink fieldCode="AU" term="%22Schick+KJ%22">Schick KJ</searchLink>; T Cell Engineering.; Division of Hematology.; Mayo Clinic Graduate School of Biomedical Sciences.; Department of Molecular Pharmacology and Experimental Therapeutics, and.<br /><searchLink fieldCode="AU" term="%22Can+I%22">Can I</searchLink>; T Cell Engineering.; Division of Hematology.; Mayo Clinic Graduate School of Biomedical Sciences.<br /><searchLink fieldCode="AU" term="%22Tapper+EE%22">Tapper EE</searchLink>; T Cell Engineering.; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Horvei+P%22">Horvei P</searchLink>; T Cell Engineering.<br /><searchLink fieldCode="AU" term="%22Adada+MM%22">Adada MM</searchLink>; T Cell Engineering.; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Bezerra+ED%22">Bezerra ED</searchLink>; T Cell Engineering.; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Kankeu+Fonkoua+LA%22">Kankeu Fonkoua LA</searchLink>; T Cell Engineering.; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Ruff+MW%22">Ruff MW</searchLink>; T Cell Engineering.; Department of Neurology, Mayo Clinic, Rochester, MN; and.<br /><searchLink fieldCode="AU" term="%22Nevala+WK%22">Nevala WK</searchLink>; Department of Immunology.<br /><searchLink fieldCode="AU" term="%22Walters+DK%22">Walters DK</searchLink>; Department of Immunology.<br /><searchLink fieldCode="AU" term="%22Parikh+SA%22">Parikh SA</searchLink>; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Jelinek+DF%22">Jelinek DF</searchLink>; Department of Immunology.<br /><searchLink fieldCode="AU" term="%22Kay+NE%22">Kay NE</searchLink>; Division of Hematology.<br /><searchLink fieldCode="AU" term="%22Bergsagel+PL%22">Bergsagel PL</searchLink>; Department of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ.<br /><searchLink fieldCode="AU" term="%22Kenderian+SS%22">Kenderian SS</searchLink>; T Cell Engineering.; Division of Hematology.; Department of Immunology.; Department of Molecular Medicine. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2022 Jun 30; Vol. 139 (26), pp. 3708-3721. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35090171 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2021012811 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3708 Titles: – TitleFull: Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sakemura R – PersonEntity: Name: NameFull: Hefazi M – PersonEntity: Name: NameFull: Siegler EL – PersonEntity: Name: NameFull: Cox MJ – PersonEntity: Name: NameFull: Larson DP – PersonEntity: Name: NameFull: Hansen MJ – PersonEntity: Name: NameFull: Manriquez Roman C – PersonEntity: Name: NameFull: Schick KJ – PersonEntity: Name: NameFull: Can I – PersonEntity: Name: NameFull: Tapper EE – PersonEntity: Name: NameFull: Horvei P – PersonEntity: Name: NameFull: Adada MM – PersonEntity: Name: NameFull: Bezerra ED – PersonEntity: Name: NameFull: Kankeu Fonkoua LA – PersonEntity: Name: NameFull: Ruff MW – PersonEntity: Name: NameFull: Nevala WK – PersonEntity: Name: NameFull: Walters DK – PersonEntity: Name: NameFull: Parikh SA – PersonEntity: Name: NameFull: Lin Y – PersonEntity: Name: NameFull: Jelinek DF – PersonEntity: Name: NameFull: Kay NE – PersonEntity: Name: NameFull: Bergsagel PL – PersonEntity: Name: NameFull: Kenderian SS IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 06 Text: 2022 Jun 30 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 139 – Type: issue Value: 26 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |